HomeNECLIFE • NSE
add
Nectar Lifesciences Ltd
Previous close
₹25.51
Day range
₹24.77 - ₹26.78
Year range
₹24.77 - ₹56.50
Market cap
5.90B INR
Avg Volume
1.13M
P/E ratio
34.63
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 4.54B | 0.48% |
Operating expense | 931.98M | -4.89% |
Net income | 78.40M | 400.38% |
Net profit margin | 1.73 | 394.29% |
Earnings per share | — | — |
EBITDA | 442.76M | 6.44% |
Effective tax rate | 37.52% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.35M | -7.94% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 10.78B | — |
Shares outstanding | 224.01M | — |
Price to book | 0.53 | — |
Return on assets | — | — |
Return on capital | 4.26% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 78.40M | 400.38% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Headquarters
Website
Employees
1,686
